Business Context and Reporting Period
This Form 8-K reports on events occurring at the 2009 Annual Meeting of Stockholders of PharmAthene, Inc. held on October 29, 2009. The filing details material modifications to the rights of security holders, specifically regarding the Board of Directors composition and the rights of 10% convertible note holders.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance actions and voting results.
Material Changes
- Board Size Increase: Stockholders voted to amend the Certificate of Incorporation to increase the maximum number of directors from eight to nine.
- Noteholder Board Representation: Stockholders voted to grant holders of the 10% convertible notes the right to designate and elect two members to the Board of Directors, provided at least 30% of the aggregate principal amount of the notes remains outstanding.
- Committee Composition: The Compensation and Governance and Nominating Committees are limited to no more than three members each while the 30% note threshold is met.
- Director Elections: Seven directors were elected to serve until the 2010 annual meeting. Two directors (James H. Cavanaugh, Ph.D. and Steven St. Peter, M.D.) were elected by noteholders.
- Auditor Ratification: Stockholders ratified the selection of Ernst & Young LLP as the independent registered accounting firm for the fiscal year ending December 31, 2009.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary contingency noted is the duration of the noteholders' board representation rights, which is contingent upon at least 30% of the 10% convertible notes remaining outstanding.
Investor Verification Checklist
- Verify the current outstanding principal amount of the 10% convertible notes to confirm if the 30% threshold for noteholder board representation is met.
- Review the Definitive Proxy Statement on Schedule 14A (filed September 29, 2009) for detailed descriptions of the amendments.
- Confirm the effective date of the amendments with the Delaware Secretary of State (filed October 29, 2009).
- Check subsequent filings for any changes in the composition of the Board of Directors or the status of the 10% Notes.